Heated Rivalry wrestles with this conundrum but ultimately resolves it in a deeply conservative way. According to the logic ...

Fosun Pharma is spending 1.4 billion Chinese yuan ($200 million) to take on a 53% stake in Green Valley Pharmaceuticals and ...

Looking toward 2026, the expectations are shifting from “what will the Fed do?” to “what will actually work?” Markets are ...

Today, race can feel like a job-market albatross in a way it hasn’t in a generation or two, as diversity initiatives are ...

Welcome to the unofficial start of NBA trade season, everybody. Let's mark the occasion by updating each squad's top-three ...

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small ...

Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...

The registered direct offering was structured as a straightforward equity investment with no warrant coverage and was led by healthcare-dedicated investors alongside existing shareholders. This ...

The probability of a 15–20 percent rally exists, but it is not a default. The more dependable strategy is to focus on breadth of earnings, balance-sheet strength, and valuation discipline rather than ...

A kettle corn business and coffee shop operating on a property that doesn't meet city code for commercial developments will ...

Amyotrophic lateral sclerosis (ALS) is probably one of the most devastating diagnoses that we should all hope to never hear. Also known as Lou Gehrig's disease, or motor neuron disease, ALS is a prog ...

International Silence in the Cambodia–Thailand Border Conflict: A Path to Peace or a Catalyst for Escalating Devastation?​ ...